CD8A and metastatic neoplasm: For all checkpoint molecules, levels of expression on the Tregs were significantly higher than on the effector T cells (both CD8+ and CD4eff) for normal tissue, primary and metastatic tumor, and PBMCs (Fig. 1B; Supplementary Fig. S3).